$VRUS Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Pharmasset Inc.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Pharmasset Inc. Get notifications about new insider transactions in Pharmasset Inc for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 29 2011 | VRUS | Pharmasset Inc | Berrey M Michelle | Chief Medical Offic ... | Option Exercise | M | 21.65 | 9,375 | 202,969 | 15,625 | |
| Apr 29 2011 | VRUS | Pharmasset Inc | Berrey M Michelle | Chief Medical Offic ... | Option Exercise | M | 18.60 | 8,437 | 156,928 | 6,563 | |
| Apr 29 2011 | VRUS | Pharmasset Inc | Berrey M Michelle | Chief Medical Offic ... | Option Exercise | M | 13.67 | 21,875 | 299,031 | 3,125 | |
| Apr 29 2011 | VRUS | Pharmasset Inc | Berrey M Michelle | Chief Medical Offic ... | Option Exercise | M | 4.20 | 10,416 | 43,747 | 49,108 | |
| Apr 29 2011 | VRUS | Pharmasset Inc | Berrey M Michelle | Chief Medical Offic ... | Sell | S | 100.60 | 9,375 | 943,125 | 0 | 9.4 K to 0 (-100.00 %) |
| Apr 29 2011 | VRUS | Pharmasset Inc | Berrey M Michelle | Chief Medical Offic ... | Buy | M | 21.65 | 9,375 | 202,969 | 9,375 | 0 to 9.4 K |
| Apr 29 2011 | VRUS | Pharmasset Inc | Berrey M Michelle | Chief Medical Offic ... | Sell | S | 100.60 | 8,437 | 848,762 | 0 | 8.4 K to 0 (-100.00 %) |
| Apr 29 2011 | VRUS | Pharmasset Inc | Berrey M Michelle | Chief Medical Offic ... | Buy | M | 18.60 | 8,437 | 156,928 | 8,437 | 0 to 8.4 K |
| Apr 29 2011 | VRUS | Pharmasset Inc | Berrey M Michelle | Chief Medical Offic ... | Sell | S | 100.60 | 21,875 | 2,200,625 | 0 | 21.9 K to 0 (-100.00 %) |
| Apr 29 2011 | VRUS | Pharmasset Inc | Berrey M Michelle | Chief Medical Offic ... | Buy | M | 13.67 | 21,875 | 299,031 | 21,875 | 0 to 21.9 K |
| Apr 29 2011 | VRUS | Pharmasset Inc | Berrey M Michelle | Chief Medical Offic ... | Sell | S | 100.60 | 10,416 | 1,047,850 | 0 | 10.4 K to 0 (-100.00 %) |
| Apr 29 2011 | VRUS | Pharmasset Inc | Berrey M Michelle | Chief Medical Offic ... | Buy | M | 4.20 | 10,416 | 43,747 | 10,416 | 0 to 10.4 K |
| Mar 25 2011 | VRUS | Pharmasset Inc | CONRAD HERBERT J | Director | Grant | A | 0.00 | 2,000 | 0 | 8,000 | 6 K to 8 K (+33.33 %) |
| Mar 25 2011 | VRUS | Pharmasset Inc | HAHN ELLIOT F | Director | Grant | A | 0.00 | 2,000 | 0 | 21,333 | 19.3 K to 21.3 K (+10.35 %) |
| Mar 25 2011 | VRUS | Pharmasset Inc | INOUYE MICHAEL K | Director | Grant | A | 0.00 | 2,000 | 0 | 10,500 | 8.5 K to 10.5 K (+23.53 %) |
| Mar 25 2011 | VRUS | Pharmasset Inc | Williamson Robert F III | Director | Grant | A | 0.00 | 2,000 | 0 | 14,666 | 12.7 K to 14.7 K (+15.79 %) |
| Mar 25 2011 | VRUS | Pharmasset Inc | Carney William J | Director | Grant | A | 0.00 | 2,000 | 0 | 72,666 | 70.7 K to 72.7 K (+2.83 %) |
| Mar 24 2011 | VRUS | Pharmasset Inc | OTTO MICHAEL J. | Chief Scientific Of ... | Option Exercise | M | 13.67 | 6,279 | 85,834 | 13,721 | |
| Mar 24 2011 | VRUS | Pharmasset Inc | OTTO MICHAEL J. | Chief Scientific Of ... | Sell | S | 64.00 | 6,279 | 401,856 | 16,689 | 23 K to 16.7 K (-27.34 %) |
| Mar 24 2011 | VRUS | Pharmasset Inc | OTTO MICHAEL J. | Chief Scientific Of ... | Buy | M | 13.67 | 6,279 | 85,834 | 22,968 | 16.7 K to 23 K (+37.62 %) |
| Oct 20 2010 | VRUS | Pharmasset Inc | CONRAD HERBERT J | Director | Option Exercise | A | 32.33 | 20,000 | 646,600 | 20,000 | |
| Dec 21 2010 | VRUS | Pharmasset Inc | HAHN ELLIOT F | Director | Option Exercise | M | 21.65 | 10,000 | 216,500 | 10,000 | |
| Dec 21 2010 | VRUS | Pharmasset Inc | HAHN ELLIOT F | Director | Option Exercise | M | 18.60 | 15,000 | 279,000 | 5,000 | |
| Dec 21 2010 | VRUS | Pharmasset Inc | HAHN ELLIOT F | Director | Option Exercise | M | 20.20 | 8,125 | 164,125 | 1,875 | |
| Dec 21 2010 | VRUS | Pharmasset Inc | HAHN ELLIOT F | Director | Option Exercise | M | 13.67 | 10,000 | 136,700 | 0 | |
| Dec 21 2010 | VRUS | Pharmasset Inc | HAHN ELLIOT F | Director | Buy | M | 21.65 | 10,000 | 216,500 | 117,124 | 107.1 K to 117.1 K (+9.33 %) |
| Dec 21 2010 | VRUS | Pharmasset Inc | HAHN ELLIOT F | Director | Buy | M | 18.60 | 15,000 | 279,000 | 107,124 | 92.1 K to 107.1 K (+16.28 %) |
| Dec 21 2010 | VRUS | Pharmasset Inc | HAHN ELLIOT F | Director | Buy | M | 20.20 | 8,125 | 164,125 | 92,124 | 84 K to 92.1 K (+9.67 %) |
| Dec 21 2010 | VRUS | Pharmasset Inc | HAHN ELLIOT F | Director | Buy | M | 13.67 | 10,000 | 136,700 | 83,999 | 74 K to 84 K (+13.51 %) |
| Oct 18 2010 | VRUS | Pharmasset Inc | BURRILL STEVEN | Director | Option Exercise | A | 32.33 | 20,000 | 646,600 | 20,000 | |
| Oct 18 2010 | VRUS | Pharmasset Inc | Williamson Robert F III | Director | Option Exercise | A | 32.33 | 20,000 | 646,600 | 20,000 | |
| Oct 18 2010 | VRUS | Pharmasset Inc | HAHN ELLIOT F | Director | Option Exercise | A | 32.33 | 20,000 | 646,600 | 20,000 | |
| Oct 18 2010 | VRUS | Pharmasset Inc | Rogers Michael D. | Chief Development O ... | Option Exercise | A | 32.33 | 25,000 | 808,250 | 25,000 | |
| Oct 18 2010 | VRUS | Pharmasset Inc | Carney William J | Director | Option Exercise | A | 32.33 | 20,000 | 646,600 | 20,000 | |
| Oct 18 2010 | VRUS | Pharmasset Inc | Price P Schaefer | President and CEO | Option Exercise | A | 32.33 | 83,300 | 2,693,089 | 83,300 | |
| Oct 18 2010 | VRUS | Pharmasset Inc | INOUYE MICHAEL K | Director | Option Exercise | A | 21.65 | 20,000 | 433,000 | 20,000 | |
| Oct 18 2010 | VRUS | Pharmasset Inc | Berrey M Michelle | Chief Medical Offic ... | Option Exercise | A | 32.33 | 29,500 | 953,735 | 29,500 | |
| Oct 18 2010 | VRUS | Pharmasset Inc | LEUTZINGER KURT | Chief Financial Off ... | Option Exercise | A | 32.33 | 29,500 | 953,735 | 29,500 | |
| Oct 18 2010 | VRUS | Pharmasset Inc | OTTO MICHAEL J. | Chief Scientific Of ... | Option Exercise | A | 32.33 | 25,000 | 808,250 | 25,000 | |
| Oct 01 2010 | VRUS | Pharmasset Inc | OTTO MICHAEL J. | Chief Scientific Of ... | Sell | S | 29.50 | 5,000 | 147,500 | 16,689 | 21.7 K to 16.7 K (-23.05 %) |
| Oct 01 2010 | VRUS | Pharmasset Inc | HAHN ELLIOT F | Director | Option Exercise | M | 4.02 | 6,666 | 26,797 | 1 | |
| Oct 01 2010 | VRUS | Pharmasset Inc | HAHN ELLIOT F | Director | Option Exercise | M | 3.87 | 8,000 | 30,960 | 0 | |
| Oct 01 2010 | VRUS | Pharmasset Inc | HAHN ELLIOT F | Director | Option Exercise | M | 3.87 | 6,667 | 25,801 | 0 | |
| Oct 01 2010 | VRUS | Pharmasset Inc | HAHN ELLIOT F | Director | Option Exercise | M | 3.00 | 3,333 | 9,999 | 0 | |
| Oct 01 2010 | VRUS | Pharmasset Inc | HAHN ELLIOT F | Director | Buy | M | 4.02 | 6,666 | 26,797 | 73,999 | 67.3 K to 74 K (+9.90 %) |
| Oct 01 2010 | VRUS | Pharmasset Inc | HAHN ELLIOT F | Director | Buy | M | 3.87 | 8,000 | 30,960 | 67,333 | 59.3 K to 67.3 K (+13.48 %) |
| Oct 01 2010 | VRUS | Pharmasset Inc | HAHN ELLIOT F | Director | Buy | M | 3.87 | 6,667 | 25,801 | 59,333 | 52.7 K to 59.3 K (+12.66 %) |
| Oct 01 2010 | VRUS | Pharmasset Inc | HAHN ELLIOT F | Director | Buy | M | 3.00 | 3,333 | 9,999 | 52,666 | 49.3 K to 52.7 K (+6.76 %) |
| Sep 29 2010 | VRUS | Pharmasset Inc | OTTO MICHAEL J. | Chief Scientific Of ... | Option Exercise | M | 4.02 | 7,811 | 31,400 | 5,000 | |
| Sep 29 2010 | VRUS | Pharmasset Inc | OTTO MICHAEL J. | Chief Scientific Of ... | Sell | S | 29.50 | 12,811 | 377,925 | 21,689 | 34.5 K to 21.7 K (-37.13 %) |
| Sep 29 2010 | VRUS | Pharmasset Inc | OTTO MICHAEL J. | Chief Scientific Of ... | Buy | M | 4.02 | 7,811 | 31,400 | 34,500 | 26.7 K to 34.5 K (+29.27 %) |
| Sep 21 2010 | VRUS | Pharmasset Inc | HAHN ELLIOT F | Director | Option Exercise | M | 3.00 | 10,000 | 30,000 | 3,333 | |
| Sep 21 2010 | VRUS | Pharmasset Inc | HAHN ELLIOT F | Director | Option Exercise | M | 6.75 | 3,333 | 22,498 | 0 | |
| Sep 21 2010 | VRUS | Pharmasset Inc | HAHN ELLIOT F | Director | Option Exercise | M | 6.75 | 3,333 | 22,498 | 0 | |
| Sep 21 2010 | VRUS | Pharmasset Inc | HAHN ELLIOT F | Director | Option Exercise | M | 6.75 | 3,333 | 22,498 | 0 | |
| Sep 21 2010 | VRUS | Pharmasset Inc | HAHN ELLIOT F | Director | Option Exercise | M | 6.75 | 3,333 | 22,498 | 0 | |
| Sep 21 2010 | VRUS | Pharmasset Inc | HAHN ELLIOT F | Director | Option Exercise | M | 6.00 | 6,667 | 40,002 | 0 | |
| Sep 21 2010 | VRUS | Pharmasset Inc | HAHN ELLIOT F | Director | Buy | M | 3.00 | 10,000 | 30,000 | 49,333 | 39.3 K to 49.3 K (+25.42 %) |
| Sep 21 2010 | VRUS | Pharmasset Inc | HAHN ELLIOT F | Director | Buy | M | 6.75 | 13,333 | 89,998 | 39,333 | 26 K to 39.3 K (+51.28 %) |
| Sep 21 2010 | VRUS | Pharmasset Inc | HAHN ELLIOT F | Director | Buy | M | 6.00 | 6,667 | 40,002 | 26,000 | 19.3 K to 26 K (+34.49 %) |
| Jul 06 2010 | VRUS | Pharmasset Inc | OTTO MICHAEL J. | Chief Scientific Of ... | Option Exercise | M | 4.02 | 7,189 | 28,900 | 12,811 | |
| Jul 06 2010 | VRUS | Pharmasset Inc | OTTO MICHAEL J. | Chief Scientific Of ... | Buy | M | 4.02 | 7,189 | 28,900 | 26,689 | 19.5 K to 26.7 K (+36.87 %) |
| Jun 18 2010 | VRUS | Pharmasset Inc | Berrey M Michelle | Chief Medical Offic ... | Sell | S | 32.53 | 2,976 | 96,807 | 0 | 3 K to 0 (-100.00 %) |
| Mar 22 2010 | VRUS | Pharmasset Inc | HAHN ELLIOT F | Director | Grant | A | 0.00 | 2,000 | 0 | 19,333 | 17.3 K to 19.3 K (+11.54 %) |
| Mar 22 2010 | VRUS | Pharmasset Inc | Williamson Robert F III | Director | Grant | A | 0.00 | 2,000 | 0 | 12,666 | 10.7 K to 12.7 K (+18.75 %) |
| Mar 22 2010 | VRUS | Pharmasset Inc | Carney William J | Director | Grant | A | 0.00 | 2,000 | 0 | 70,666 | 68.7 K to 70.7 K (+2.91 %) |
| Mar 22 2010 | VRUS | Pharmasset Inc | BURRILL STEVEN | Director | Grant | A | 0.00 | 2,000 | 0 | 6,000 | 4 K to 6 K (+50.00 %) |
| Mar 22 2010 | VRUS | Pharmasset Inc | CONRAD HERBERT J | Director | Grant | A | 0.00 | 2,000 | 0 | 6,000 | 4 K to 6 K (+50.00 %) |
| Mar 22 2010 | VRUS | Pharmasset Inc | INOUYE MICHAEL K | Director | Grant | A | 0.00 | 2,000 | 0 | 8,500 | 6.5 K to 8.5 K (+30.77 %) |
| Mar 04 2010 | VRUS | Pharmasset Inc | PRICE FREDRIC D | Director | Option Exercise | M | 5.45 | 1,668 | 9,082 | 1 | |
| Mar 04 2010 | VRUS | Pharmasset Inc | PRICE FREDRIC D | Director | Buy | M | 5.45 | 1,668 | 9,082 | 30,666 | 29 K to 30.7 K (+5.75 %) |
| Jan 28 2010 | VRUS | Pharmasset Inc | Carney William J | Director | Option Exercise | M | 4.02 | 5,000 | 20,100 | 0 | |
| Jan 28 2010 | VRUS | Pharmasset Inc | Carney William J | Director | Option Exercise | M | 3.87 | 2,500 | 9,675 | 0 | |
| Jan 28 2010 | VRUS | Pharmasset Inc | Carney William J | Director | Buy | M | 4.02 | 5,000 | 20,100 | 68,666 | 63.7 K to 68.7 K (+7.85 %) |
| Jan 28 2010 | VRUS | Pharmasset Inc | Carney William J | Director | Buy | M | 3.87 | 2,500 | 9,675 | 63,666 | 61.2 K to 63.7 K (+4.09 %) |
| Dec 07 2009 | VRUS | Pharmasset Inc | PRICE FREDRIC D | Director | Option Exercise | M | 5.45 | 1,666 | 9,071 | 1,669 | |
| Dec 07 2009 | VRUS | Pharmasset Inc | PRICE FREDRIC D | Director | Buy | M | 5.45 | 1,666 | 9,071 | 28,998 | 27.3 K to 29 K (+6.10 %) |
| Oct 26 2009 | VRUS | Pharmasset Inc | Rogers Michael D. | Chief Development O ... | Option Exercise | A | 21.65 | 20,000 | 433,000 | 20,000 | |
| Oct 26 2009 | VRUS | Pharmasset Inc | LUBETKIN PAUL | Executive VP & Gene ... | Option Exercise | A | 21.65 | 18,333 | 396,909 | 18,333 | |
| Oct 26 2009 | VRUS | Pharmasset Inc | Carney William J | Director | Option Exercise | A | 21.65 | 20,000 | 433,000 | 20,000 | |
| Oct 26 2009 | VRUS | Pharmasset Inc | BURRILL STEVEN | Director | Option Exercise | A | 21.65 | 20,000 | 433,000 | 20,000 | |
| Oct 26 2009 | VRUS | Pharmasset Inc | INOUYE MICHAEL K | Director | Option Exercise | A | 21.65 | 20,000 | 433,000 | 20,000 | |
| Oct 26 2009 | VRUS | Pharmasset Inc | HAHN ELLIOT F | Director | Option Exercise | A | 21.65 | 20,000 | 433,000 | 20,000 | |
| Oct 26 2009 | VRUS | Pharmasset Inc | CONRAD HERBERT J | Director | Option Exercise | A | 21.65 | 20,000 | 433,000 | 20,000 | |
| Oct 26 2009 | VRUS | Pharmasset Inc | Williamson Robert F III | Director | Option Exercise | A | 21.65 | 20,000 | 433,000 | 20,000 | |
| Oct 26 2009 | VRUS | Pharmasset Inc | PRICE FREDRIC D | Director | Option Exercise | A | 21.65 | 20,000 | 433,000 | 20,000 | |
| Oct 26 2009 | VRUS | Pharmasset Inc | Price P Schaefer | President and CEO | Option Exercise | A | 21.65 | 50,000 | 1,082,500 | 50,000 | |
| Oct 26 2009 | VRUS | Pharmasset Inc | OTTO MICHAEL J. | Chief Scientific Of ... | Option Exercise | A | 21.65 | 20,000 | 433,000 | 20,000 | |
| Oct 26 2009 | VRUS | Pharmasset Inc | LEUTZINGER KURT | Chief Financial Off ... | Option Exercise | A | 21.65 | 25,000 | 541,250 | 25,000 | |
| Oct 26 2009 | VRUS | Pharmasset Inc | Berrey M Michelle | Chief Medical Offic ... | Option Exercise | A | 21.65 | 25,000 | 541,250 | 25,000 | |
| Sep 24 2009 | VRUS | Pharmasset Inc | QVT Associates GP LLC | 10% Owner | Sell | S | 20.88 | 400,000 | 8,352,000 | 2,793,274 | 3.2 M to 2.8 M (-12.53 %) |
| Sep 24 2009 | VRUS | Pharmasset Inc | QVT Associates GP LLC | 10% Owner | Sell | S | 20.88 | 400,000 | 8,352,000 | 3,193,274 | 3.6 M to 3.2 M (-11.13 %) |
| Sep 24 2009 | VRUS | Pharmasset Inc | QVT Associates GP LLC | 10% Owner | Sell | S | 22.41 | 10,000 | 224,100 | 3,593,274 | 3.6 M to 3.6 M (-0.28 %) |
| Sep 24 2009 | VRUS | Pharmasset Inc | QVT Associates GP LLC | 10% Owner | Sell | S | 22.95 | 100,000 | 2,295,000 | 3,603,274 | 3.7 M to 3.6 M (-2.70 %) |
| Sep 21 2009 | VRUS | Pharmasset Inc | OTTO MICHAEL | Exec.VP,Pharm.Resea ... | Option Exercise | M | 3.87 | 40,000 | 154,800 | 0 | |
| Sep 21 2009 | VRUS | Pharmasset Inc | OTTO MICHAEL | Exec.VP,Pharm.Resea ... | Sell | S | 21.97 | 4,600 | 101,062 | 19,500 | 24.1 K to 19.5 K (-19.09 %) |
| Sep 21 2009 | VRUS | Pharmasset Inc | OTTO MICHAEL | Exec.VP,Pharm.Resea ... | Sell | S | 21.95 | 4,500 | 98,775 | 2,410 | 6.9 K to 2.4 K (-65.12 %) |
| Sep 21 2009 | VRUS | Pharmasset Inc | OTTO MICHAEL | Exec.VP,Pharm.Resea ... | Sell | S | 21.94 | 8,200 | 179,908 | 28,600 | 36.8 K to 28.6 K (-22.28 %) |
| Sep 21 2009 | VRUS | Pharmasset Inc | OTTO MICHAEL | Exec.VP,Pharm.Resea ... | Sell | S | 21.92 | 9,300 | 203,856 | 36,800 | 46.1 K to 36.8 K (-20.17 %) |
| Sep 21 2009 | VRUS | Pharmasset Inc | OTTO MICHAEL | Exec.VP,Pharm.Resea ... | Sell | S | 21.90 | 13,400 | 293,460 | 46,100 | 59.5 K to 46.1 K (-22.52 %) |
| Sep 21 2009 | VRUS | Pharmasset Inc | OTTO MICHAEL | Exec.VP,Pharm.Resea ... | Buy | M | 3.87 | 40,000 | 154,800 | 59,500 | 19.5 K to 59.5 K (+205.13 %) |
| Sep 03 2009 | VRUS | Pharmasset Inc | PRICE FREDRIC D | Director | Option Exercise | M | 5.45 | 1,666 | 9,071 | 3,335 | |
| Sep 03 2009 | VRUS | Pharmasset Inc | PRICE FREDRIC D | Director | Buy | M | 5.45 | 1,666 | 9,071 | 27,332 | 25.7 K to 27.3 K (+6.49 %) |
| Jun 02 2009 | VRUS | Pharmasset Inc | PRICE FREDRIC D | Director | Option Exercise | M | 5.45 | 21,666 | 117,971 | 5,001 | |
| Jun 02 2009 | VRUS | Pharmasset Inc | PRICE FREDRIC D | Director | Buy | M | 5.45 | 21,666 | 117,971 | 25,666 | 4 K to 25.7 K (+541.65 %) |
| Mar 26 2009 | VRUS | Pharmasset Inc | BURRILL STEVEN | Director | Grant | A | 0.00 | 2,000 | 0 | 4,000 | 2 K to 4 K (+100.00 %) |
| Mar 26 2009 | VRUS | Pharmasset Inc | HAHN ELLIOT F | Director | Grant | A | 0.00 | 2,000 | 0 | 17,333 | 15.3 K to 17.3 K (+13.04 %) |
| Mar 26 2009 | VRUS | Pharmasset Inc | PRICE FREDRIC D | Director | Grant | A | 0.00 | 2,000 | 0 | 4,000 | 2 K to 4 K (+100.00 %) |
| Mar 26 2009 | VRUS | Pharmasset Inc | INOUYE MICHAEL K | Director | Grant | A | 0.00 | 2,000 | 0 | 6,500 | 4.5 K to 6.5 K (+44.44 %) |
| Mar 26 2009 | VRUS | Pharmasset Inc | Williamson Robert F III | Director | Grant | A | 0.00 | 2,000 | 0 | 10,666 | 8.7 K to 10.7 K (+23.08 %) |
| Mar 26 2009 | VRUS | Pharmasset Inc | CONRAD HERBERT J | Director | Grant | A | 0.00 | 2,000 | 0 | 4,000 | 2 K to 4 K (+100.00 %) |
| Mar 26 2009 | VRUS | Pharmasset Inc | Carney William J | Director | Grant | A | 0.00 | 2,000 | 0 | 61,166 | 59.2 K to 61.2 K (+3.38 %) |
| Mar 02 2009 | VRUS | Pharmasset Inc | INOUYE MICHAEL K | Director | Buy | P | 10.11 | 200 | 2,022 | 4,500 | 4.3 K to 4.5 K (+4.65 %) |
| Mar 02 2009 | VRUS | Pharmasset Inc | INOUYE MICHAEL K | Director | Buy | P | 10.10 | 192 | 1,939 | 4,300 | 4.1 K to 4.3 K (+4.67 %) |
| Mar 02 2009 | VRUS | Pharmasset Inc | INOUYE MICHAEL K | Director | Buy | P | 10.09 | 300 | 3,027 | 4,108 | 3.8 K to 4.1 K (+7.88 %) |
| Mar 02 2009 | VRUS | Pharmasset Inc | INOUYE MICHAEL K | Director | Buy | P | 10.07 | 58 | 584 | 3,808 | 3.8 K to 3.8 K (+1.55 %) |
| Mar 02 2009 | VRUS | Pharmasset Inc | INOUYE MICHAEL K | Director | Buy | P | 10.11 | 500 | 5,053 | 3,750 | 3.3 K to 3.8 K (+15.38 %) |
| Mar 02 2009 | VRUS | Pharmasset Inc | INOUYE MICHAEL K | Director | Buy | P | 10.68 | 119 | 1,271 | 3,250 | 3.1 K to 3.3 K (+3.80 %) |
| Mar 02 2009 | VRUS | Pharmasset Inc | INOUYE MICHAEL K | Director | Buy | P | 10.67 | 100 | 1,067 | 3,131 | 3 K to 3.1 K (+3.30 %) |
| Mar 02 2009 | VRUS | Pharmasset Inc | INOUYE MICHAEL K | Director | Buy | P | 10.64 | 200 | 2,128 | 3,031 | 2.8 K to 3 K (+7.06 %) |
| Mar 02 2009 | VRUS | Pharmasset Inc | INOUYE MICHAEL K | Director | Buy | P | 10.65 | 300 | 3,195 | 2,831 | 2.5 K to 2.8 K (+11.85 %) |
| Mar 02 2009 | VRUS | Pharmasset Inc | INOUYE MICHAEL K | Director | Buy | P | 10.63 | 300 | 3,189 | 2,531 | 2.2 K to 2.5 K (+13.45 %) |
| Mar 02 2009 | VRUS | Pharmasset Inc | INOUYE MICHAEL K | Director | Buy | P | 10.60 | 131 | 1,389 | 2,231 | 2.1 K to 2.2 K (+6.24 %) |
| Mar 02 2009 | VRUS | Pharmasset Inc | INOUYE MICHAEL K | Director | Buy | P | 10.59 | 100 | 1,059 | 2,100 | 2 K to 2.1 K (+5.00 %) |
| Feb 26 2009 | VRUS | Pharmasset Inc | LUBETKIN PAUL | Executive VP & Gene ... | Buy | P | 10.14 | 125 | 1,268 | 500 | 375 to 500 (+33.33 %) |
| Feb 26 2009 | VRUS | Pharmasset Inc | LUBETKIN PAUL | Executive VP & Gene ... | Buy | P | 10.65 | 175 | 1,864 | 375 | 200 to 375 (+87.50 %) |
| Feb 26 2009 | VRUS | Pharmasset Inc | LUBETKIN PAUL | Executive VP & Gene ... | Buy | P | 10.64 | 200 | 2,128 | 200 | 0 to 200 |
| Nov 25 2008 | VRUS | Pharmasset Inc | CONRAD HERBERT J | Director | Option Exercise | A | 18.60 | 20,000 | 372,000 | 20,000 | |
| Nov 19 2008 | VRUS | Pharmasset Inc | BURRILL STEVEN | Director | Option Exercise | A | 18.60 | 20,000 | 372,000 | 20,000 | |
| Nov 19 2008 | VRUS | Pharmasset Inc | PRICE FREDRIC D | Director | Option Exercise | A | 18.60 | 20,000 | 372,000 | 20,000 | |
| Nov 19 2008 | VRUS | Pharmasset Inc | HAHN ELLIOT F | Director | Option Exercise | A | 18.60 | 20,000 | 372,000 | 20,000 | |
| Nov 19 2008 | VRUS | Pharmasset Inc | OTTO MICHAEL | Chief Scientific Of ... | Option Exercise | A | 18.60 | 15,000 | 279,000 | 15,000 | |
| Nov 19 2008 | VRUS | Pharmasset Inc | LEUTZINGER KURT | Chief Financial Off ... | Option Exercise | A | 18.60 | 10,000 | 186,000 | 10,000 | |
| Nov 19 2008 | VRUS | Pharmasset Inc | Berrey M Michelle | Chief Medical Offic ... | Option Exercise | A | 18.60 | 15,000 | 279,000 | 15,000 | |
| Nov 19 2008 | VRUS | Pharmasset Inc | INOUYE MICHAEL K | Director | Option Exercise | A | 18.60 | 20,000 | 372,000 | 20,000 | |
| Nov 19 2008 | VRUS | Pharmasset Inc | Williamson Robert F III | Director | Option Exercise | A | 18.60 | 20,000 | 372,000 | 20,000 | |
| Nov 19 2008 | VRUS | Pharmasset Inc | Price P Schaefer | President and CEO | Option Exercise | A | 18.60 | 30,000 | 558,000 | 30,000 | |
| Nov 19 2008 | VRUS | Pharmasset Inc | Carney William J | Director | Option Exercise | A | 18.60 | 20,000 | 372,000 | 20,000 | |
| Nov 17 2008 | VRUS | Pharmasset Inc | Rogers Michael D. | Chief Development O ... | Sell | S | 18.75 | 600 | 11,250 | 0 | 600 to 0 (-100.00 %) |
| Nov 17 2008 | VRUS | Pharmasset Inc | Rogers Michael D. | Chief Development O ... | Sell | S | 18.72 | 1 | 19 | 600 | 601 to 600 (-0.17 %) |
| Nov 17 2008 | VRUS | Pharmasset Inc | Rogers Michael D. | Chief Development O ... | Sell | S | 18.71 | 300 | 5,613 | 601 | 901 to 601 (-33.30 %) |
| Nov 17 2008 | VRUS | Pharmasset Inc | Rogers Michael D. | Chief Development O ... | Sell | S | 18.70 | 300 | 5,610 | 901 | 1.2 K to 901 (-24.98 %) |
| Nov 17 2008 | VRUS | Pharmasset Inc | Rogers Michael D. | Chief Development O ... | Sell | S | 18.69 | 499 | 9,326 | 1,201 | 1.7 K to 1.2 K (-29.35 %) |
| Nov 17 2008 | VRUS | Pharmasset Inc | Rogers Michael D. | Chief Development O ... | Sell | S | 18.65 | 701 | 13,074 | 1,700 | 2.4 K to 1.7 K (-29.20 %) |
| Nov 17 2008 | VRUS | Pharmasset Inc | Rogers Michael D. | Chief Development O ... | Sell | S | 18.63 | 100 | 1,863 | 2,401 | 2.5 K to 2.4 K (-4.00 %) |
| Nov 17 2008 | VRUS | Pharmasset Inc | Rogers Michael D. | Chief Development O ... | Sell | S | 18.62 | 400 | 7,448 | 2,501 | 2.9 K to 2.5 K (-13.79 %) |
| Nov 17 2008 | VRUS | Pharmasset Inc | Rogers Michael D. | Chief Development O ... | Option Exercise | M | 13.88 | 16,672 | 231,407 | 63,250 | |
| Nov 17 2008 | VRUS | Pharmasset Inc | Rogers Michael D. | Chief Development O ... | Sell | S | 18.59 | 100 | 1,859 | 2,901 | 3 K to 2.9 K (-3.33 %) |
| Nov 17 2008 | VRUS | Pharmasset Inc | Rogers Michael D. | Chief Development O ... | Sell | S | 18.58 | 200 | 3,716 | 3,001 | 3.2 K to 3 K (-6.25 %) |
| Nov 17 2008 | VRUS | Pharmasset Inc | Rogers Michael D. | Chief Development O ... | Sell | S | 18.55 | 99 | 1,836 | 3,201 | 3.3 K to 3.2 K (-3.00 %) |